PROK Competitors & Alternatives
Compare ProKidney Corp. with similar stocks in the same industry
Biotechnology
PROK
Main Stock$1.77
Tradestie Score
56
Market Cap
$350.98M
Revenue Growth
0.0%
Analyst Upside
+253.1%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SVRA
Savara Inc.
|
$5.83
|
$611.84M | - | 61 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.32
|
$552.46M | - | 58 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$12.95
|
$540.97M | - | 54 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.08
|
$529.35M | 6.5 | 63 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.22
|
$512.39M | - | 57 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$36.55
|
$505.12M | 1.8 | 54 | Compare |
|
RGNX
REGENXBIO Inc.
|
$9.97
|
$493.52M | - | 56 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$95.14
|
$492.21M | - | 51 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$42.15
|
$474.20M | 26.7 | 58 | Compare |
More PROK Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry